Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERX BIOPHARMACEUTICALS Key Ratios

  • Valuation Ratio: RGN

    P/E (TTM) -5.62
    Price to CashFlow -5.11
    Price to Sales (TTM) 357.58
    Price to Book 82.68
  • Per Share Ratio: RGN

    Dividend Per Share (TTM) 0.00
    Book Value Per Share -0.01
    EPS Fully Diluted -0.21
    Revenue Per Share 0.0033
  • 5 Year Annual Growth: RGN

    Net Income
    Revenue 0.00%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: RGN

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: RGN

    Operations Margin -6,404.97%
    Net Profit Margin -6,316.04%
    Gross Profit Margin 88.48%
  • Financial Strength: RGN

    Quick Ratio (MRQ) 4.27
    Current Ratio (MRQ) 1.65
    LT Debt to Equity (MRQ) 0.00
    Total Debt to Equity (MRQ) 0.00
    Return on Equity (ROE) Per Share -192.77
    Return on Assets (ROA) -224.74
    Return on Invested Capital (ROIC) -197.91
  • Assets: RGN

    Asset Turnover 0.03
    Inventory Turnover